FDA Approves Dapagliflozin for Type 2 Diabetes (FREE)
By Amy Orciari Herman
Dapagliflozin (Farxiga) — an inhibitor of sodium-glucose co-transporter 2 — has been approved as an adjunct to diet and exercise in adults with type 2 diabetes, the …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news
More News: Dapagliflozin | Diabetes | Diabetes Type 2 | Endocrinology | Forxiga | Nutrition | Primary Care | Sports Medicine